Jun 2026 (Q2 FY26) — Aug 11, 2026
United States Antimony Corporation Q2 FY26 — Antimony Price Headwinds Offset by Zeolite Growth and DLA Deliveries
Read the full callUnited States Antimony (UAMY) earnings
- Jun 2026
- Jun 2026 (Q2 FY26)
- Dec 2025
United States Antimony earnings: last reported Tue, 11 Aug 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 7.9 | −24.7% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | -88.1 | −88.3 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | 0.11 | −39.3% YoY | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. |
Price
$3.1 +8.77% · +$0.25
Performance −72.3% 1Y
1Y: $11.19 on 17 Oct 2025 → $3.1. High $13.43 (20 Oct 2025), low $2.78 (15 Oct 2026).
- Previous close
- $2.85
- 52-week range
- $2.78 – $13.43
- One year
- −76.92%
Overview
- Symbol
- UAMY
- Sector
- Materials
- Exchange
- US
- Currency
- USD
Call summaries
Every analysed call
United States Antimony earnings calls (UAMY)
Financials
What the filings say
Net profit, year on year: −39% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 3 | 7 | 7 | 11 | 9 | 13 | 7 | 8 |
| Operating profit | -1 | -1 | 0 | 0 | -5 | -4 | -8 | -7 |
| Operating margin | −34.6% | −18.4% | 5.1% | 0.2% | −56.5% | −30.1% | −110.8% | −88.1% |
| Other income | 0 | 0 | 0 | 0 | 0 | 4 | -4 | 7 |
| Profit before tax | — | — | 1 | 0 | — | — | -11 | 0 |
| Tax rate | — | — | 0.0% | 0.0% | — | — | — | 0.0% |
| Net profit | -1 | -1 | 1 | 0 | -5 | -0 | -11 | 0 |
| EPS ($ per share) | -0.01 | — | 0 | — | -0.04 | — | -0.08 | — |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Reserves | -26 | -29 | -33 | -33 | -33 | -39 | -41 | -45 |
| Total liabilities | 6 | 5 | 6 | 3 | 3 | 3 | 6 | 13 |
| Fixed assets | 15 | 12 | 11 | 11 | 12 | 13 | 13 | 42 |
| Total assets | 18 | 14 | 13 | 35 | 35 | 28 | 35 | 154 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | -1 | -0 | -1 | -2 | -0 | -5 | 2 | -10 |
| Cash from investing | 1 | -0 | -0 | -1 | -2 | -1 | -0 | -87 |
| Cash from financing | -0 | 0 | 2 | 24 | -0 | -1 | 4 | 109 |
| Capital expenditure | -1 | -1 | -0 | -1 | -2 | -2 | -0 | -28 |
| Free cash flow | -2 | -1 | -2 | -3 | -2 | -6 | 2 | -37 |
Insider filings
32 filings between Jan 15, 2026 and Sep 1, 2026.
Open market
decisions to buy or sellPurchases
$391.8K
5 purchases by 5 insiders
Sales
None
No insider sold shares.
Compensation
not trading decisions- 3
- Award — granted as compensation
Also filed: 24 dispositions to the issuer.
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Carrabba Joseph A | $100.5K | — | Sep 1, 2026 |
| EVANS GARY C | $98.4K | — | Aug 28, 2026 |
| Marinelli Jon R | $93.1K | — | Jun 15, 2026 |
| Bardswich Lloyd | $92.7K | — | Sep 1, 2026 |
| Aguirre Blaise A. | $7.0K | — | Aug 31, 2026 |
Latest filings (46)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Sep 1, 2026 | Bardswich Lloyd Dir, EVP & Chief Mining Eng | Purchase | 20,000 | $92.7K |
| Sep 1, 2026 | Carrabba Joseph A Director | Purchase | 21,300 | $100.5K |
| Aug 31, 2026 | Aguirre Blaise A. Director | Purchase | 1,400 | $7.0K |
| Aug 28, 2026 | EVANS GARY C Chairman & CEO | Purchase | 20,000 | $98.4K |
| Jun 15, 2026 | Marinelli Jon R Director | Purchase | 12,500 | $93.1K |
| Jun 2, 2026 | ISAAK RICHARD R SVP, Chief Financial Officer | Disposition to issuer | 100,000 | $975.0K |
| Apr 2, 2026 | Bardswich Lloyd Dir, EVP & Chief Mining Eng | Disposition to issuer | 59,872 | $537.7K |
| Mar 31, 2026 | Aguirre Blaise A. Director | Disposition to issuer | 8,400 | $69.1K |
| Mar 31, 2026 | Aguirre Blaise A. Director | Disposition to issuer | 9,600 | $79.1K |
| Mar 31, 2026 | Aguirre Blaise A. Director | Disposition to issuer | 3,000 | $24.8K |
| Mar 31, 2026 | Aguirre Blaise A. Director | Disposition to issuer | 1,000 | $8.2K |
| Mar 31, 2026 | Aguirre Blaise A. Director | Disposition to issuer | 5,000 | $41.0K |
| Mar 27, 2026 | Bardswich Lloyd Dir, EVP & Chief Mining Eng | Disposition to issuer | 36,181 | $327.4K |
| Mar 27, 2026 | Aguirre Blaise A. Director | Disposition to issuer | 5,373 | $47.1K |
| Mar 27, 2026 | Aguirre Blaise A. Director | Disposition to issuer | 6,339 | $55.7K |
| Mar 26, 2026 | Bardswich Lloyd Dir, EVP & Chief Mining Eng | Disposition to issuer | 46,674 | $435.9K |
| Mar 26, 2026 | ISAAK RICHARD R SVP, Chief Financial Officer | Disposition to issuer | 53,334 | $480.0K |
| Mar 25, 2026 | EVANS GARY C Chairman & CEO | Disposition to issuer | 100,000 | $988.0K |
| Mar 25, 2026 | ISAAK RICHARD R SVP, Chief Financial Officer | Disposition to issuer | 30,000 | $300.0K |
| Mar 25, 2026 | EVANS GARY C Chairman & CEO | Disposition to issuer | 100,000 | $985.0K |
| Mar 25, 2026 | EVANS GARY C Chairman & CEO | Disposition to issuer | 100,000 | $981.0K |
| Mar 25, 2026 | EVANS GARY C Chairman & CEO | Disposition to issuer | 100,000 | $976.0K |
| Mar 25, 2026 | Fink Jeffrey Russell VP, General Manager, BRZ | Disposition to issuer | 10,000 | $96.9K |
| Mar 25, 2026 | Fink Jeffrey Russell VP, General Manager, BRZ | Disposition to issuer | 10,000 | $100.0K |
| Mar 25, 2026 | Fink Jeffrey Russell VP, General Manager, BRZ | Disposition to issuer | 4,055 | $40.5K |
| Mar 24, 2026 | Aguirre Blaise A. Director | Disposition to issuer | 20,000 | $183.2K |
| Mar 23, 2026 | Pagen Melissa President & COO of BRZ | Disposition to issuer | 89,004 | $813.5K |
| Mar 23, 2026 | Fink Jeffrey Russell VP, General Manager, BRZ | Disposition to issuer | 5,000 | $44.5K |
| Mar 23, 2026 | Fink Jeffrey Russell VP, General Manager, BRZ | Disposition to issuer | 5,000 | $45.5K |
| Jan 15, 2026 | MCMANUS MICHAEL A JR Director | Award | 6,635 | $0 |
| Jan 15, 2026 | Aguirre Blaise A. Director | Award | 6,635 | $0 |
| Jan 15, 2026 | Carrabba Joseph A Director | Award | 6,635 | $0 |
| Oct 3, 2025 | Fink Jeffrey Russell VP, General Manager BRZ | Disposition to issuer | 2,833 | $23.1K |
| Oct 3, 2025 | Fink Jeffrey Russell VP, General Manager BRZ | Disposition to issuer | 8,000 | $65.0K |
| Oct 1, 2025 | MCMANUS MICHAEL A JR Director | Disposition to issuer | 50,000 | $365.8K |
| Oct 1, 2025 | ISAAK RICHARD R SVP, Chief Financial Officer | Disposition to issuer | 50,000 | $350.0K |
| Sep 29, 2025 | Bardswich Lloyd Dir, EVP & Chief Mining Eng | Disposition to issuer | 40,000 | $257.6K |
| Sep 26, 2025 | EVANS GARY C Chairman & CEO | Purchase | 100,000 | $613.2K |
| Sep 24, 2025 | Fink Jeffrey Russell VP, General Manager BRZ | Disposition to issuer | 12,500 | $98.4K |
| May 27, 2025 | Carrabba Joseph A Director | Award | 22,733 | $0 |
| May 27, 2025 | Aguirre Blaise A. Director | Award | 22,733 | $0 |
| May 27, 2025 | MCMANUS MICHAEL A JR Director | Award | 22,733 | $0 |
| Dec 10, 2024 | EVANS GARY C Chairman & CEO | Purchase | 200,000 | $289.4K |
| Dec 10, 2024 | MCMANUS MICHAEL A JR Director | Purchase | 70,000 | $102.1K |
| Nov 18, 2024 | MCMANUS MICHAEL A JR Director | Purchase | 50,000 | $28.2K |
| Sep 9, 2024 | ISAAK RICHARD R SVP, Chief Financial Officer | Purchase | 5,000 | $3.4K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for UNITED STATES ANTIMONY CORP
Free account. Everything above stays public.
Write why you follow UNITED STATES ANTIMONY CORP and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading